Bank of America’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.73M | Sell |
327,211
-87,975
| -21% | -$1M | ﹤0.01% | 3543 |
|
|
2025
Q1 | $4.93M | Buy |
415,186
+264,251
| +175% | +$3.14M | ﹤0.01% | 3223 |
|
|
2024
Q4 | $2.84M | Buy |
150,935
+12,811
| +9% | +$241K | ﹤0.01% | 3491 |
|
|
2024
Q3 | $3.1M | Sell |
138,124
-83,203
| -38% | -$1.87M | ﹤0.01% | 3549 |
|
|
2024
Q2 | $4.62M | Buy |
221,327
+124,151
| +128% | +$2.59M | ﹤0.01% | 3154 |
|
|
2024
Q1 | $1.43M | Buy |
97,176
+78,240
| +413% | +$1.15M | ﹤0.01% | 3941 |
|
|
2023
Q4 | $195K | Sell |
18,936
-527,514
| -97% | -$5.44M | ﹤0.01% | 5175 |
|
|
2023
Q3 | $4.3M | Sell |
546,450
-41,575
| -7% | -$327K | ﹤0.01% | 2952 |
|
|
2023
Q2 | $5.87M | Sell |
588,025
-43,179
| -7% | -$431K | ﹤0.01% | 2737 |
|
|
2023
Q1 | $5.61M | Sell |
631,204
-90,335
| -13% | -$802K | ﹤0.01% | 2921 |
|
|
2022
Q4 | $7.92M | Buy |
721,539
+591,198
| +454% | +$6.49M | ﹤0.01% | 2470 |
|
|
2022
Q3 | $1.7M | Buy |
130,341
+42,527
| +48% | +$554K | ﹤0.01% | 3789 |
|
|
2022
Q2 | $1.11M | Buy |
87,814
+35,264
| +67% | +$447K | ﹤0.01% | 4173 |
|
|
2022
Q1 | $736K | Sell |
52,550
-35,965
| -41% | -$504K | ﹤0.01% | 4827 |
|
|
2021
Q4 | $2.56M | Buy |
88,515
+13,443
| +18% | +$389K | ﹤0.01% | 3694 |
|
|
2021
Q3 | $2.25M | Buy |
75,072
+47,163
| +169% | +$1.41M | ﹤0.01% | 3704 |
|
|
2021
Q2 | $740K | Sell |
27,909
-3,395
| -11% | -$90K | ﹤0.01% | 4456 |
|
|
2021
Q1 | $973K | Buy |
31,304
+24,047
| +331% | +$747K | ﹤0.01% | 4272 |
|
|
2020
Q4 | $239K | Sell |
7,257
-1,262
| -15% | -$41.6K | ﹤0.01% | 4775 |
|
|
2020
Q3 | $298K | Buy |
+8,519
| New | +$298K | ﹤0.01% | 4471 |
|